Correlation Between Enliven Therapeutics and Estrella Immunopharma
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Estrella Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Estrella Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Estrella Immunopharma, you can compare the effects of market volatilities on Enliven Therapeutics and Estrella Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Estrella Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Estrella Immunopharma.
Diversification Opportunities for Enliven Therapeutics and Estrella Immunopharma
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Enliven and Estrella is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Estrella Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Estrella Immunopharma and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Estrella Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Estrella Immunopharma has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Estrella Immunopharma go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Estrella Immunopharma
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Estrella Immunopharma. In addition to that, Enliven Therapeutics is 4.99 times more volatile than Estrella Immunopharma. It trades about -0.19 of its total potential returns per unit of risk. Estrella Immunopharma is currently generating about -0.58 per unit of volatility. If you would invest 9.20 in Estrella Immunopharma on September 3, 2024 and sell it today you would lose (0.10) from holding Estrella Immunopharma or give up 1.09% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 15.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Estrella Immunopharma
Performance |
| Timeline |
| Enliven Therapeutics |
| Estrella Immunopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
OK
Enliven Therapeutics and Estrella Immunopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Estrella Immunopharma
The main advantage of trading using opposite Enliven Therapeutics and Estrella Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Estrella Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Estrella Immunopharma will offset losses from the drop in Estrella Immunopharma's long position.| Enliven Therapeutics vs. DiaMedica Therapeutics | Enliven Therapeutics vs. Lyra Therapeutics | Enliven Therapeutics vs. Centessa Pharmaceuticals PLC |
| Estrella Immunopharma vs. Chipotle Mexican Grill | Estrella Immunopharma vs. Dine Brands Global | Estrella Immunopharma vs. Arm Holdings plc | Estrella Immunopharma vs. Starbucks |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |